All stock lists
Vivos Inc (RDGL)
United States · Delayed Price · Currency is USD
Healthcare · Medical Devices
0.04-0.00 (-4.01%)
Market cap
$21.9M
Website
Insider Score
––Not scored
RDGL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RDGL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 36.40 K | 36.07 K | 24.75 K | 1.88 K | 15.00 K | — |
| Revenue Growth (YoY) | 142.67 % | — | — | — | — | — |
| Cost of Revenue | 38.12 K | 44.09 K | 27.86 K | 14.69 K | 49.75 K | — |
| Gross Profit | -1.72 K | -8.02 K | -3.10 K | -12.81 K | -34.75 K | — |
| SG&A Expense | 603.63 K | 499.55 K | 1.04 M | 450.39 K | 532.05 K | — |
| R&D Expense | 49.18 K | 37.92 K | 57.17 K | 67.82 K | 107.97 K | — |
| Operating Expenses | 652.81 K | 537.47 K | 1.09 M | 518.21 K | 640.02 K | — |
| Operating Income | -654.53 K | -545.49 K | -1.10 M | -531.02 K | -674.77 K | — |
| Pretax Income | -830.19 K | -1.18 M | -1.08 M | -507.29 K | -645.51 K | — |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -830.19 K | -1.18 M | -1.08 M | -507.29 K | -645.51 K | — |
| EPS (Basic) | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| EPS (Diluted) | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| Shares Outstanding | 490.70 M | 462.16 M | — | 454.30 M | 453.51 M | 448.23 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.